Pelvic Neoplasms
📧 Sign up to get email alerts when something new happens for Pelvic Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors [Phase 3]
A Phase 3 clinical trial is evaluating pafolacianine as an imaging agent to identify lesions in pediatric patients with primary or metastati…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy [Phase 2]
Phase 2 trial evaluating oral iohexol for management of chylous ascites after retroperitoneal or extended lymphadenectomy; the study status …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Pelvis Adaptive Radiotherapy (ART) [NA]
Recruiting for a pelvic neoplasm trial evaluating pelvis adaptive radiotherapy (ART); the status is recruiting and no phase information is p…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
A clinical trial update noting recruiting status for a study on quality of life and function after hemipelvectomy in patients with malignant…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients [Phase 1]
Phase Ib study evaluating the combination of sunitinib with radiation therapy for cancer has completed, including head and neck cancer and o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Oncologic Therapy Support Via Means of a Dedicated Mobile App [NA]
Heidelberg University is reporting a clinical trial update on a mobile app designed to support oncologic therapy, investigating its use acro…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors [Phase 1]
A Phase 1 trial at St. Jude Children's Research Hospital determined a safe dose of the ultrasound contrast agent Optison in pediatric patien…